Asian Internal Neurostimulaiton/Neuromodulation Market, by Modality (Spinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, Gastric Neurostimulator) - Forecast to 2019
The Asia-Pacific internal neurostimulation/neuromodulation market is estimated to register a CAGR of 13.8% between 2014 and 2019. Although the mature market of Japan holds the largest share in the internal neurostimulation/neuromodulation market, India is estimated to register the highest CAGR of 15.3% during the forecast period. The growth of the internal neurostimulation/neuromodulation market in Asia-Pacific is driven by public initiatives to increase awareness, technological developments, growing demand for the use of advanced technologies, and increasingly aging population. However, factors including lack of skilled professional and unfavorable reimbursement scenario are restraining the growth of this market.
In this report, the Asia-Pacific internal neurostimulation/neuromodulation market has been broadly classified into spinal cord stimulator, deep brain stimulator, sacral nerve stimulator, vagus nerve stimulator, and gastric neurostimulator. The Spinal Cord Stimulator segment is further categorized by application into Chronic Pain, Failed Back Surgery Syndrome, Ischemic Pain and others. Likewise, Deep Brain Stimulation market has its application in Parkinson's Disease, Tremor, Depression, and others including Chronic Pain, Dystonia, Tourette's Syndrome, and Alzheimer's disease. Sacral Nerve Stimulation market has applications in Urinary Incontinence and Fecal Incontinence, while Vagus Nerve Stimulator comprises Epilepsy and other applications. Gastric Stimulation includes gastroparesis and others. The gastric neurostimulator market segment is estimated to register the highest CAGR between 2014 and 2019. The driver for this market is the increasing number of people suffering from severe GERD and gastroparesis. Most incidences of delayed bowel movement go unnoticed, which offers a significant growth opportunity for players in this segment.
In terms of countries, Japan is estimated to command the largest share of 53.0% of the Asia-Pacific internal neurostimulation/neuromodulation market in 2014, followed by China. The internal neurostimulation/neuromodulation market in the Japan is primarily driven by factors including aging population, technological advancements, and rising government initiatives.
The Asia-Pacific Internal neurostimulation/neuromodulation market is a competitive market with a number of market players with niche technologies. As of 2014, this market was dominated by Medtronic Inc. (U.S.), St. Jude Medical Inc. (U.S.), Boston Scientific Inc. (U.S.) Depuy Synthes, Inc. (U.S.), Cyberonics Inc. (U.S.), Enteromedics Inc. (U.S.), and Uroplasty, Inc. (U.S.) New product launches and partnerships, agreements, collaborations, and joint ventures are the main strategies adopted by most market players to achieve growth.
Reasons to Buy the Report:
From an insight perspective, this research report focuses on various levels of analysis—industry analysis (industry trends, and PEST analysis), market share analysis of top players, supply chain analysis, and company profiles, which together comprise and discuss the basic views on the competitive landscape, emerging and high-growth segments of the Asia-Pacific internal neurostimulation/neuromodulation market, regulatory policies of different countries, government initiatives, drivers, restraints, and upcoming opportunities.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share.
The report provides insights on the following pointers:
In this report, the Asia-Pacific internal neurostimulation/neuromodulation market has been broadly classified into spinal cord stimulator, deep brain stimulator, sacral nerve stimulator, vagus nerve stimulator, and gastric neurostimulator. The Spinal Cord Stimulator segment is further categorized by application into Chronic Pain, Failed Back Surgery Syndrome, Ischemic Pain and others. Likewise, Deep Brain Stimulation market has its application in Parkinson's Disease, Tremor, Depression, and others including Chronic Pain, Dystonia, Tourette's Syndrome, and Alzheimer's disease. Sacral Nerve Stimulation market has applications in Urinary Incontinence and Fecal Incontinence, while Vagus Nerve Stimulator comprises Epilepsy and other applications. Gastric Stimulation includes gastroparesis and others. The gastric neurostimulator market segment is estimated to register the highest CAGR between 2014 and 2019. The driver for this market is the increasing number of people suffering from severe GERD and gastroparesis. Most incidences of delayed bowel movement go unnoticed, which offers a significant growth opportunity for players in this segment.
In terms of countries, Japan is estimated to command the largest share of 53.0% of the Asia-Pacific internal neurostimulation/neuromodulation market in 2014, followed by China. The internal neurostimulation/neuromodulation market in the Japan is primarily driven by factors including aging population, technological advancements, and rising government initiatives.
The Asia-Pacific Internal neurostimulation/neuromodulation market is a competitive market with a number of market players with niche technologies. As of 2014, this market was dominated by Medtronic Inc. (U.S.), St. Jude Medical Inc. (U.S.), Boston Scientific Inc. (U.S.) Depuy Synthes, Inc. (U.S.), Cyberonics Inc. (U.S.), Enteromedics Inc. (U.S.), and Uroplasty, Inc. (U.S.) New product launches and partnerships, agreements, collaborations, and joint ventures are the main strategies adopted by most market players to achieve growth.
Reasons to Buy the Report:
From an insight perspective, this research report focuses on various levels of analysis—industry analysis (industry trends, and PEST analysis), market share analysis of top players, supply chain analysis, and company profiles, which together comprise and discuss the basic views on the competitive landscape, emerging and high-growth segments of the Asia-Pacific internal neurostimulation/neuromodulation market, regulatory policies of different countries, government initiatives, drivers, restraints, and upcoming opportunities.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share.
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on internal neuromodulation technologies offered by the top 10 players in the neuromodulation technologies market
- Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the Asia-Pacific internal neurostimulation/neuromodulation market
- Market Development: Comprehensive information about emerging markets. The report analyzes the markets for various segments of the Asia-Pacific internal neurostimulation/neuromodulation market across geographies
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Asia-Pacific internal neurostimulation/neuromodulation market
- Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of leading players in the Asia-Pacific internal neurostimulation/neuromodulation market
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET SEGMENTATION & COVERAGE
1.3 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 INTEGRATED ECOSYSTEM OF THE INTERNAL NEUROSTIMULATION / NEUROMODULATION MARKET
2.2 ARRIVING AT THE NEUROMOSTIMULATION/NEUROMODULATION MARKET SIZE
2.2.1 MARKET SHARE
2.2.2 TOP-DOWN APPROACH
2.2.3 BOTTOM-UP APPROACH
2.2.4 MACRO INDICATOR-BASED APPROACH
2.3 ASIA-PACIFIC INTERNAL NEUROMODULATION/NEUROSTIMULATION MARKET: MACRO INDICATORS, BY GEOGRAPHY, 2014 ($ BN)
2.4 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET: COMPARISON WITH THE PARENT MARKET
4.3 MARKET DRIVERS AND INHIBITORS
5 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET, BY MODALITY
5.1 INTRODUCTION
5.2 SPINAL CORD STIMULATION
5.3 DEEP BRAIN STIMULATION
5.4 SACRAL NERVE STIMULATION
5.5 VAGUS NERVE STIMULATON
5.6 GASTRIC ELECTRICAL STIMULATION (GES)
6 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET, BY APPLICATION
6.1 INTRODUCTION
6.1.1 ASIA-PACIFIC SPINAL CORD STIMULATION (SCS) MARKET, BY APPLICATION
6.1.2 ASIA-PACIFIC DEEP BRAIN STIMULATION (DBS) MARKET, BY APPLICATION
6.1.3 SACRAL NERVE STIMULATION (SNS) MARKET, BY APPLICATION
6.1.4 VAGUS NERVE STIMULATION (VNS) MARKET, BY APPLICATION
6.1.5 GASTRIC ELECTRICAL STIMULATION (GES) MARKET, BY APPLICATION
7 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET, BY GEOGRAPHY
7.1 INTRODUCTION
7.1.1 JAPAN INTERNAL NEUROSTIMULATION MARKET, BY MODALITY
7.1.2 SPINAL CORD STIMULATION (SCS) NEUROSTIMULATION MARKET IN JAPAN, BY APPLICATION
7.1.3 DEEP BRAIN STIMULATION (DBS) NEUROSTIMULATION MARKET IN JAPAN, BY APPLICATION
7.1.4 CHINA INTERNAL NEUROSTIMULATION MARKET, BY MODALITY
7.1.5 SPINAL CORD STIMULATION (SCS) NEUROSTIMULATION MARKET IN CHINA, BY APPLICATION
7.1.6 DEEP BRAIN STIMULATION (SCS) NEUROSTIMULATION MARKET IN CHINA, BY APPLICATION
7.1.7 DEEP BRAIN STIMULATION (SCS) NEUROSTIMULATION MARKET IN CHINA, BY APPLICATION
7.1.8 INDIA INTERNAL NEUROSTIMULATION MARKET, BY MODALITY
7.1.9 SPINAL CORD STIMULATION (SCS) NEUROSTIMULATION MARKET IN INDIA, BY APPLICATION
7.1.10 DEEP BRAIN STIMULATION (SCS) NEUROSTIMULATION MARKET IN INDIA, BY APPLICATION
7.1.11 REPUBLIC OF KOREA INTERNAL NEUROSTIMULATION MARKET, BY MODALITY
7.1.12 DEEP BRAIN STIMULATION (DBS) NEUROSTIMULATION MARKET IN REPUBLIC OF KOREA, BY APPLICATION
7.1.13 REST OF ASIA INTERNAL NEUROSTIMULATION MARKET, BY MODALITY
7.1.14 SPINAL CORD STIMULATION (SCS) NEUROSTIMULATION MARKET IN REST OF ASIA, BY APPLICATION
7.1.15 DEEP BRAIN STIMULATION (DBS) NEUROSTIMULATION MARKET IN REST OF ASIA, BY APPLICATION
8 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET: COMPETITIVE LANDSCAPE
8.1 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET: BY COMPANY
8.2 NEW PRODUCT LAUNCH
9 INTERNAL NEUROSTIMULATION/ NEUROMODULATION MARKET, BY COMPANY
(Overview, Financials, Products & Services, Strategy, and Developments)*
9.1 BOSTON SCIENTIFIC CORPORATION (U.S.)
9.2 CERBOMED GMBH (GERMANY)
9.3 CYBERONICS, INC. (U.S.)
9.4 DEPUY SYNTHES COMPANIES (U.S.)
9.5 ENTEROMEDICS, INC. (U.S.)
9.6 MEDTRONIC, INC. (U.S.)
9.7 ST. JUDE MEDICAL (U.S.)
9.8 SYNAPSE BIOMEDICAL, INC. (U.S.)
9.9 UROPLASTY, INC. (U.S.)
*Details on overview, financials, product & services, strategy, and developments might not be captured in case of unlisted company
10 APPENDIX
10.1 CUSTOMIZATION OPTIONS
10.1.1 PRODUCT ANALYSIS
10.1.2 EPIDEMIOLOGY DATA
10.1.3 SURGEONS/PHYSICIANS PERCEPTION ANALYSIS
10.1.4 REGULATORY FRAMEWORK
10.2 RELATED REPORTS
10.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
10.3.1 SNAPSHOTS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET SEGMENTATION & COVERAGE
1.3 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 INTEGRATED ECOSYSTEM OF THE INTERNAL NEUROSTIMULATION / NEUROMODULATION MARKET
2.2 ARRIVING AT THE NEUROMOSTIMULATION/NEUROMODULATION MARKET SIZE
2.2.1 MARKET SHARE
2.2.2 TOP-DOWN APPROACH
2.2.3 BOTTOM-UP APPROACH
2.2.4 MACRO INDICATOR-BASED APPROACH
2.3 ASIA-PACIFIC INTERNAL NEUROMODULATION/NEUROSTIMULATION MARKET: MACRO INDICATORS, BY GEOGRAPHY, 2014 ($ BN)
2.4 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET: COMPARISON WITH THE PARENT MARKET
4.3 MARKET DRIVERS AND INHIBITORS
5 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET, BY MODALITY
5.1 INTRODUCTION
5.2 SPINAL CORD STIMULATION
5.3 DEEP BRAIN STIMULATION
5.4 SACRAL NERVE STIMULATION
5.5 VAGUS NERVE STIMULATON
5.6 GASTRIC ELECTRICAL STIMULATION (GES)
6 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET, BY APPLICATION
6.1 INTRODUCTION
6.1.1 ASIA-PACIFIC SPINAL CORD STIMULATION (SCS) MARKET, BY APPLICATION
6.1.2 ASIA-PACIFIC DEEP BRAIN STIMULATION (DBS) MARKET, BY APPLICATION
6.1.3 SACRAL NERVE STIMULATION (SNS) MARKET, BY APPLICATION
6.1.4 VAGUS NERVE STIMULATION (VNS) MARKET, BY APPLICATION
6.1.5 GASTRIC ELECTRICAL STIMULATION (GES) MARKET, BY APPLICATION
7 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET, BY GEOGRAPHY
7.1 INTRODUCTION
7.1.1 JAPAN INTERNAL NEUROSTIMULATION MARKET, BY MODALITY
7.1.2 SPINAL CORD STIMULATION (SCS) NEUROSTIMULATION MARKET IN JAPAN, BY APPLICATION
7.1.3 DEEP BRAIN STIMULATION (DBS) NEUROSTIMULATION MARKET IN JAPAN, BY APPLICATION
7.1.4 CHINA INTERNAL NEUROSTIMULATION MARKET, BY MODALITY
7.1.5 SPINAL CORD STIMULATION (SCS) NEUROSTIMULATION MARKET IN CHINA, BY APPLICATION
7.1.6 DEEP BRAIN STIMULATION (SCS) NEUROSTIMULATION MARKET IN CHINA, BY APPLICATION
7.1.7 DEEP BRAIN STIMULATION (SCS) NEUROSTIMULATION MARKET IN CHINA, BY APPLICATION
7.1.8 INDIA INTERNAL NEUROSTIMULATION MARKET, BY MODALITY
7.1.9 SPINAL CORD STIMULATION (SCS) NEUROSTIMULATION MARKET IN INDIA, BY APPLICATION
7.1.10 DEEP BRAIN STIMULATION (SCS) NEUROSTIMULATION MARKET IN INDIA, BY APPLICATION
7.1.11 REPUBLIC OF KOREA INTERNAL NEUROSTIMULATION MARKET, BY MODALITY
7.1.12 DEEP BRAIN STIMULATION (DBS) NEUROSTIMULATION MARKET IN REPUBLIC OF KOREA, BY APPLICATION
7.1.13 REST OF ASIA INTERNAL NEUROSTIMULATION MARKET, BY MODALITY
7.1.14 SPINAL CORD STIMULATION (SCS) NEUROSTIMULATION MARKET IN REST OF ASIA, BY APPLICATION
7.1.15 DEEP BRAIN STIMULATION (DBS) NEUROSTIMULATION MARKET IN REST OF ASIA, BY APPLICATION
8 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET: COMPETITIVE LANDSCAPE
8.1 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET: BY COMPANY
8.2 NEW PRODUCT LAUNCH
9 INTERNAL NEUROSTIMULATION/ NEUROMODULATION MARKET, BY COMPANY
(Overview, Financials, Products & Services, Strategy, and Developments)*
9.1 BOSTON SCIENTIFIC CORPORATION (U.S.)
9.2 CERBOMED GMBH (GERMANY)
9.3 CYBERONICS, INC. (U.S.)
9.4 DEPUY SYNTHES COMPANIES (U.S.)
9.5 ENTEROMEDICS, INC. (U.S.)
9.6 MEDTRONIC, INC. (U.S.)
9.7 ST. JUDE MEDICAL (U.S.)
9.8 SYNAPSE BIOMEDICAL, INC. (U.S.)
9.9 UROPLASTY, INC. (U.S.)
*Details on overview, financials, product & services, strategy, and developments might not be captured in case of unlisted company
10 APPENDIX
10.1 CUSTOMIZATION OPTIONS
10.1.1 PRODUCT ANALYSIS
10.1.2 EPIDEMIOLOGY DATA
10.1.3 SURGEONS/PHYSICIANS PERCEPTION ANALYSIS
10.1.4 REGULATORY FRAMEWORK
10.2 RELATED REPORTS
10.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
10.3.1 SNAPSHOTS
LIST OF TABLES
Table 1 ASIA-PACIFIC INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET: COMPARISON WITH PARENT MARKET, 2013 – 2018 (USD MN)
Table 2 INTERNAL NEUROMODULATION/NEUROSTIMULATION MARKET, BY GEOGRAPHY, 2013 - 2019 (USD THOUSAND)
Table 3 INTERNAL NEUROMODULATION/NEUROSTIMULATION MARKET IN ASIA-PACIFIC: DRIVERS AND INHIBITORS
Table 4 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN ASIA-PACIFIC, BY MODALITY, 2013 - 2019 (USD THOUSAND)
Table 5 SPINAL CORD STIMULATION MARKET, BY GEOGRAPHY, 2013–2019 (USD THOUSAND)
Table 6 DEEP BRAIN STIMULATION MARKET, BY GEOGRAPHY, 2013–2019 (USD THOUSAND)
Table 7 SACRAL NERVE STIMULATION MARKET, BY GEOGRAPHY, 2013–2019 (USD THOUSAND)
Table 8 VAGUS NERVE STIMULATION MARKET, BY GEOGRAPHY, 2013–2019 (USD THOUSAND)
Table 9 GASTRIC ELECTRICAL STIMULATION MASKS MARKET, BY GEOGRAPHY, 2013–2019 (USD THOUSAND)
Table 10 ASIA-PACIFIC SPINAL CORD STIMULATION (SCS) MARKET, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 11 ASIA-PACIFIC DEEP BRAIN STIMULATION (DBS) MARKET, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 12 ASIA-PACIFIC SACRAL NERVE STIMULATION (SNS) MARKET, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 13 ASIA-PACIFIC VAGUS NERVE STIMULATION (VNS) MARKET, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 14 ASIA-PACIFIC GASTRIC ELECTRIC STIMULATION (GES) MARKET, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 15 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN JAPAN, BY MODALITY, 2013 - 2019 (USD THOUSAND)
Table 16 SPINAL CORD STIMULATION (SCS) MARKET IN JAPAN, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 17 DEEP BRAIN STIMULATION (DBS) MARKET IN JAPAN, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 18 SACRAL NERVE STIMULATION (SNS) MARKET IN JAPAN, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 19 VAGUS NERVE STIMULATION (VNS) MARKET IN JAPAN, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 20 GASTRIC ELECTRICAL STIMULATION (GES) MARKET IN JAPAN, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 21 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN CHINA, BY MODALITY, 2013 - 2019 (USD THOUSAND)
Table 22 SPINAL CORD STIMULATION (SCS) MARKET IN CHINA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 23 DEEP BRAIN STIMULATION (DBS) MARKET IN CHINA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 24 SACRAL NERVE STIMULATION (SNS) MARKET IN CHINA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 25 VAGUS NERVE STIMULATION (VNS) MARKET IN CHINA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 26 GASTRIC ELECTRICAL STIMULATION (GES) MARKET IN CHINA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 27 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN INDIA, BY MODALITY, 2013 - 2019 (USD THOUSAND)
Table 28 SPINAL CORD STIMULATION (SCS) MARKET IN INDIA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 29 DEEP BRAIN STIMULATION (DBS) MARKET IN INDIA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 30 SACRAL NERVE STIMULATION (SNS) MARKET IN INDIA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 31 VAGUS NERVE STIMULATION (VNS) MARKET IN INDIA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 32 GASTRIC ELECTRICAL STIMULATION (GES) MARKET IN INDIA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 33 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN REPUBLIC OF KOREA, BY MODALITY, 2013 - 2019 (USD THOUSAND)
Table 34 SPINAL CORD STIMULATION (SCS) MARKET IN REPUBLIC OF KOREA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 35 DEEP BRAIN STIMULATION (DBS) MARKET IN REPUBLIC OF KOREA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 36 SACRAL NERVE STIMULATION (SNS) MARKET IN REPUBLIC OF KOREA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 37 VAGUS NERVE STIMULATION (VNS) MARKET IN REPUBLIC OF KOREA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 38 GASTRIC ELECTRICAL STIMULATION (GES) MARKET IN REPUBLIC OF KOREA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 39 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN REST OF ASIA, BY MODALITY, 2013 - 2019 (USD THOUSAND)
Table 40 SPINAL CORD STIMULATION (SCS) MARKET IN REST OF ASIA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 41 DEEP BRAIN STIMULATION (DBS) MARKET IN REST OF ASIA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 42 SACRAL NERVE STIMULATION (SNS) MARKET IN REST OF ASIA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 43 VAGUS NERVE STIMULATION (VNS) MARKET IN REST OF ASIA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 44 GASTRIC ELECTRICAL STIMULATION (GES) MARKET IN REST OF ASIA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 45 ASIA-PACIFIC INTERNAL NEUROMODULATION MARKET: NEW PRODUCT LAUNCH
Table 46 REGULATORY APPROVALS ASIA-PACIFIC INTERNAL NEUROMODULATION MARKET: REGULATORY APPROVALS
Table 47 BOSTON SCIENTIFIC CORPORATION: KEY FINANCIALS,BY SEGMENT, 2009 – 2013 (USD MILLION)
Table 48 BOSTON SCIENTIFIC: KEY FINANCIALS, BY GEOGRAPHY, 2009 – 2012 (USD MILLION)
Table 49 CYBERONICS, INC.: KEY FINANCIALS, 2009 - 2013 (USD MILLION)
Table 50 JOHNSON & JOHNSON, INC.: KEY FINANCIALS, BY SEGMENT, 2009 - 2013 (USD MILLION)
Table 51 JOHNSON & JOHNSON, INC.: KEY FINANCIALS, 2009 - 2013 (USD MILLION)
Table 52 MEDTRONIC, INC.: KEY FINANCIALS, BY SEGMENT, 2009 - 2013 (USD MILLION)
Table 53 MEDTRONIC, INC.: KEY FINANCIALS, 2009 - 2013 (USD MILLION)
Table 54 ST. JUDE MEDICAL: KEY FINANCIALS, BY SEGMENT, 2011 - 2013 (USD MILLION)
Table 55 ST. JUDE MEDICAL: KEY FINANCIALS, BY GEOGRAPHY, 2008 - 2013 (USD MILLION)
Table 56 UROPLASTY, INC.: KEY FINANCIALS, BY GEOGRAPHY, 2011 - 2013 (USD MILLION)
Table 1 ASIA-PACIFIC INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET: COMPARISON WITH PARENT MARKET, 2013 – 2018 (USD MN)
Table 2 INTERNAL NEUROMODULATION/NEUROSTIMULATION MARKET, BY GEOGRAPHY, 2013 - 2019 (USD THOUSAND)
Table 3 INTERNAL NEUROMODULATION/NEUROSTIMULATION MARKET IN ASIA-PACIFIC: DRIVERS AND INHIBITORS
Table 4 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN ASIA-PACIFIC, BY MODALITY, 2013 - 2019 (USD THOUSAND)
Table 5 SPINAL CORD STIMULATION MARKET, BY GEOGRAPHY, 2013–2019 (USD THOUSAND)
Table 6 DEEP BRAIN STIMULATION MARKET, BY GEOGRAPHY, 2013–2019 (USD THOUSAND)
Table 7 SACRAL NERVE STIMULATION MARKET, BY GEOGRAPHY, 2013–2019 (USD THOUSAND)
Table 8 VAGUS NERVE STIMULATION MARKET, BY GEOGRAPHY, 2013–2019 (USD THOUSAND)
Table 9 GASTRIC ELECTRICAL STIMULATION MASKS MARKET, BY GEOGRAPHY, 2013–2019 (USD THOUSAND)
Table 10 ASIA-PACIFIC SPINAL CORD STIMULATION (SCS) MARKET, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 11 ASIA-PACIFIC DEEP BRAIN STIMULATION (DBS) MARKET, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 12 ASIA-PACIFIC SACRAL NERVE STIMULATION (SNS) MARKET, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 13 ASIA-PACIFIC VAGUS NERVE STIMULATION (VNS) MARKET, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 14 ASIA-PACIFIC GASTRIC ELECTRIC STIMULATION (GES) MARKET, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 15 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN JAPAN, BY MODALITY, 2013 - 2019 (USD THOUSAND)
Table 16 SPINAL CORD STIMULATION (SCS) MARKET IN JAPAN, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 17 DEEP BRAIN STIMULATION (DBS) MARKET IN JAPAN, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 18 SACRAL NERVE STIMULATION (SNS) MARKET IN JAPAN, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 19 VAGUS NERVE STIMULATION (VNS) MARKET IN JAPAN, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 20 GASTRIC ELECTRICAL STIMULATION (GES) MARKET IN JAPAN, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 21 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN CHINA, BY MODALITY, 2013 - 2019 (USD THOUSAND)
Table 22 SPINAL CORD STIMULATION (SCS) MARKET IN CHINA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 23 DEEP BRAIN STIMULATION (DBS) MARKET IN CHINA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 24 SACRAL NERVE STIMULATION (SNS) MARKET IN CHINA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 25 VAGUS NERVE STIMULATION (VNS) MARKET IN CHINA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 26 GASTRIC ELECTRICAL STIMULATION (GES) MARKET IN CHINA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 27 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN INDIA, BY MODALITY, 2013 - 2019 (USD THOUSAND)
Table 28 SPINAL CORD STIMULATION (SCS) MARKET IN INDIA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 29 DEEP BRAIN STIMULATION (DBS) MARKET IN INDIA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 30 SACRAL NERVE STIMULATION (SNS) MARKET IN INDIA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 31 VAGUS NERVE STIMULATION (VNS) MARKET IN INDIA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 32 GASTRIC ELECTRICAL STIMULATION (GES) MARKET IN INDIA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 33 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN REPUBLIC OF KOREA, BY MODALITY, 2013 - 2019 (USD THOUSAND)
Table 34 SPINAL CORD STIMULATION (SCS) MARKET IN REPUBLIC OF KOREA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 35 DEEP BRAIN STIMULATION (DBS) MARKET IN REPUBLIC OF KOREA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 36 SACRAL NERVE STIMULATION (SNS) MARKET IN REPUBLIC OF KOREA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 37 VAGUS NERVE STIMULATION (VNS) MARKET IN REPUBLIC OF KOREA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 38 GASTRIC ELECTRICAL STIMULATION (GES) MARKET IN REPUBLIC OF KOREA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 39 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN REST OF ASIA, BY MODALITY, 2013 - 2019 (USD THOUSAND)
Table 40 SPINAL CORD STIMULATION (SCS) MARKET IN REST OF ASIA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 41 DEEP BRAIN STIMULATION (DBS) MARKET IN REST OF ASIA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 42 SACRAL NERVE STIMULATION (SNS) MARKET IN REST OF ASIA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 43 VAGUS NERVE STIMULATION (VNS) MARKET IN REST OF ASIA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 44 GASTRIC ELECTRICAL STIMULATION (GES) MARKET IN REST OF ASIA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Table 45 ASIA-PACIFIC INTERNAL NEUROMODULATION MARKET: NEW PRODUCT LAUNCH
Table 46 REGULATORY APPROVALS ASIA-PACIFIC INTERNAL NEUROMODULATION MARKET: REGULATORY APPROVALS
Table 47 BOSTON SCIENTIFIC CORPORATION: KEY FINANCIALS,BY SEGMENT, 2009 – 2013 (USD MILLION)
Table 48 BOSTON SCIENTIFIC: KEY FINANCIALS, BY GEOGRAPHY, 2009 – 2012 (USD MILLION)
Table 49 CYBERONICS, INC.: KEY FINANCIALS, 2009 - 2013 (USD MILLION)
Table 50 JOHNSON & JOHNSON, INC.: KEY FINANCIALS, BY SEGMENT, 2009 - 2013 (USD MILLION)
Table 51 JOHNSON & JOHNSON, INC.: KEY FINANCIALS, 2009 - 2013 (USD MILLION)
Table 52 MEDTRONIC, INC.: KEY FINANCIALS, BY SEGMENT, 2009 - 2013 (USD MILLION)
Table 53 MEDTRONIC, INC.: KEY FINANCIALS, 2009 - 2013 (USD MILLION)
Table 54 ST. JUDE MEDICAL: KEY FINANCIALS, BY SEGMENT, 2011 - 2013 (USD MILLION)
Table 55 ST. JUDE MEDICAL: KEY FINANCIALS, BY GEOGRAPHY, 2008 - 2013 (USD MILLION)
Table 56 UROPLASTY, INC.: KEY FINANCIALS, BY GEOGRAPHY, 2011 - 2013 (USD MILLION)
LIST OF FIGURES
Figure 1 ASIA-PACIFIC NEUROSTIMULATION/NEUROMODULATION MARKET SEGMENTATION & COVERAGE
Figure 2 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET: INTEGRATED ECOSYSTEM
Figure 3 TOP-DOWN APPROACH
Figure 4 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN ASIA-PACIFIC, BY COUNTRY, 2013–2019 (USD MN)
Figure 5 ASIA-PACIFIC INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET, BY MODALITY, 2013–2019 (USD THOUSAND)
Figure 6 SPINAL CORD STIMULATION MARKET, BY GEOGRAPHY, 2013–2019 (USD THOUSAND)
Figure 7 DEEP BRAIN STIMULATION MARKET, BY GEOGRAPHY, 2013–2019 (USD THOUSAND)
Figure 8 SACRAL NERVE STIMULATION MARKET, BY GEOGRAPHY, 2013–2019 (USD THOUSAND)
Figure 9 VAGUS NERVE STIMULATION MARKET, BY GEOGRAPHY, 2013–2019 (USD THOUSAND)
Figure 10 GASTRIC ELECTRICAL STIMULATION MASKS MARKET, BY GEOGRAPHY, 2013–2019 (USD THOUSAND)
Figure 11 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN JAPAN, BY MODALITY, 2013–2019 (USD THOUSAND)
Figure 12 SPINAL CORD STIMULATION (SCS) MARKET IN JAPAN, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Figure 13 DEEP BRAIN STIMULATION (DBS) MARKET IN JAPAN, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Figure 14 SACRAL NERVE STIMULATION (SNS) MARKET IN JAPAN, BY APPLICATION, 2013 - 2019 (USD MN)
Figure 15 VAGUS NERVE STIMULATION (VNS) MARKET IN JAPAN, BY APPLICATION, 2013 - 2019 (USD MN)
Figure 16 GASTRIC ELECTRICAL STIMULATION (GES) MARKET IN JAPAN, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Figure 17 CHINA INTERNAL NEUROSTIMULATION MARKET OVERVIEW, 2014 & 2019 (%)
Figure 18 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN CHINA, BY MODALITY, 2013–2019 (USD THOUSAND)
Figure 19 SPINAL CORD STIMULATION (SCS) MARKET IN CHINA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Figure 20 DEEP BRAIN STIMULATION (DBS) MARKET IN CHINA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Figure 21 SACRAL NERVE STIMULATION (SNS) MARKET IN CHINA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Figure 22 VAGUS NERVE STIMULATION (VNS) MARKET IN CHINA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Figure 23 GASTRIC ELECTRICAL STIMULATION (GES) MARKET IN CHINA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Figure 24 INDIA INTERNAL NEUROSTIMULATION MARKET OVERVIEW, 2014 & 2019 (%)
Figure 25 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN INDIA, BY MODALITY, 2013–2019 (USD THOUSAND)
Figure 26 SPINAL CORD STIMULATION (SCS) MARKET IN INDIA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Figure 27 DEEP BRAIN STIMULATION (DBS) MARKET IN INDIA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Figure 28 SACRAL NERVE STIMULATION (SNS) MARKET IN INDIA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Figure 29 VAGUS NERVE STIMULATION (VNS) MARKET IN INDIA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Figure 30 GASTRIC ELECTRICAL STIMULATION (GES) MARKET IN INDIA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Figure 31 REPUBLIC OF KOREA INTERNAL NEUROSTIMULATION MARKET OVERVIEW, 2014 & 2019 (%)
Figure 32 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN REPUBLIC OF KOREA, BY MODALITY, 2013–2019 (USD THOUSAND)
Figure 33 SPINAL CORD STIMULATION (SCS) MARKET IN REPUBLIC OF KOREA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Figure 34 DEEP BRAIN STIMULATION (DBS) MARKET IN REPUBLIC OF KOREA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Figure 35 SACRAL NERVE STIMULATION (SNS) MARKET IN REPUBLIC OF KOREA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Figure 36 VAGUS NERVE STIMULATION (VNS) MARKET IN REPUBLIC OF KOREA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Figure 37 GASTRIC ELECTRICAL STIMULATION (GES) MARKET IN REPUBLIC OF KOREA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Figure 38 REST OF ASIA INTERNAL NEUROSTIMULATION MARKET OVERVIEW, 2014 & 2019 (%)
Figure 39 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN REST OF ASIA, BY MODALITY, 2013–2019 (USD THOUSAND)
Figure 40 SPINAL CORD STIMULATION (SCS) MARKET IN REST OF ASIA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Figure 41 DEEP BRAIN STIMULATION (DBS) MARKET IN REST OF ASIA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Figure 42 SACRAL NERVE STIMULATION (SNS) MARKET IN REST OF ASIA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Figure 43 VAGUS NERVE STIMULATION (VNS) MARKET IN REST OF ASIA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Figure 44 GASTRIC ELECTRICAL STIMULATION (GES) MARKET IN REST OF ASIA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Figure 45 INTERNAL NEUROSTIMULATION/ NEUROMODULATION MARKET: BY COMPANY
Figure 46 BOSTON SCIENTIFIC CORPORATION REVENUE MIX, 2013
Figure 47 JOHNSON & JOHNSON, INC. REVENUE MIX, 2013
Figure 48 MEDTRONIC, INC. REVENUE MIX, 2013
Figure 49 ST. JUDE MEDICAL. REVENUE MIX, 2013
Figure 1 ASIA-PACIFIC NEUROSTIMULATION/NEUROMODULATION MARKET SEGMENTATION & COVERAGE
Figure 2 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET: INTEGRATED ECOSYSTEM
Figure 3 TOP-DOWN APPROACH
Figure 4 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN ASIA-PACIFIC, BY COUNTRY, 2013–2019 (USD MN)
Figure 5 ASIA-PACIFIC INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET, BY MODALITY, 2013–2019 (USD THOUSAND)
Figure 6 SPINAL CORD STIMULATION MARKET, BY GEOGRAPHY, 2013–2019 (USD THOUSAND)
Figure 7 DEEP BRAIN STIMULATION MARKET, BY GEOGRAPHY, 2013–2019 (USD THOUSAND)
Figure 8 SACRAL NERVE STIMULATION MARKET, BY GEOGRAPHY, 2013–2019 (USD THOUSAND)
Figure 9 VAGUS NERVE STIMULATION MARKET, BY GEOGRAPHY, 2013–2019 (USD THOUSAND)
Figure 10 GASTRIC ELECTRICAL STIMULATION MASKS MARKET, BY GEOGRAPHY, 2013–2019 (USD THOUSAND)
Figure 11 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN JAPAN, BY MODALITY, 2013–2019 (USD THOUSAND)
Figure 12 SPINAL CORD STIMULATION (SCS) MARKET IN JAPAN, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Figure 13 DEEP BRAIN STIMULATION (DBS) MARKET IN JAPAN, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Figure 14 SACRAL NERVE STIMULATION (SNS) MARKET IN JAPAN, BY APPLICATION, 2013 - 2019 (USD MN)
Figure 15 VAGUS NERVE STIMULATION (VNS) MARKET IN JAPAN, BY APPLICATION, 2013 - 2019 (USD MN)
Figure 16 GASTRIC ELECTRICAL STIMULATION (GES) MARKET IN JAPAN, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Figure 17 CHINA INTERNAL NEUROSTIMULATION MARKET OVERVIEW, 2014 & 2019 (%)
Figure 18 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN CHINA, BY MODALITY, 2013–2019 (USD THOUSAND)
Figure 19 SPINAL CORD STIMULATION (SCS) MARKET IN CHINA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Figure 20 DEEP BRAIN STIMULATION (DBS) MARKET IN CHINA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Figure 21 SACRAL NERVE STIMULATION (SNS) MARKET IN CHINA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Figure 22 VAGUS NERVE STIMULATION (VNS) MARKET IN CHINA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Figure 23 GASTRIC ELECTRICAL STIMULATION (GES) MARKET IN CHINA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Figure 24 INDIA INTERNAL NEUROSTIMULATION MARKET OVERVIEW, 2014 & 2019 (%)
Figure 25 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN INDIA, BY MODALITY, 2013–2019 (USD THOUSAND)
Figure 26 SPINAL CORD STIMULATION (SCS) MARKET IN INDIA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Figure 27 DEEP BRAIN STIMULATION (DBS) MARKET IN INDIA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Figure 28 SACRAL NERVE STIMULATION (SNS) MARKET IN INDIA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Figure 29 VAGUS NERVE STIMULATION (VNS) MARKET IN INDIA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Figure 30 GASTRIC ELECTRICAL STIMULATION (GES) MARKET IN INDIA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Figure 31 REPUBLIC OF KOREA INTERNAL NEUROSTIMULATION MARKET OVERVIEW, 2014 & 2019 (%)
Figure 32 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN REPUBLIC OF KOREA, BY MODALITY, 2013–2019 (USD THOUSAND)
Figure 33 SPINAL CORD STIMULATION (SCS) MARKET IN REPUBLIC OF KOREA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Figure 34 DEEP BRAIN STIMULATION (DBS) MARKET IN REPUBLIC OF KOREA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Figure 35 SACRAL NERVE STIMULATION (SNS) MARKET IN REPUBLIC OF KOREA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Figure 36 VAGUS NERVE STIMULATION (VNS) MARKET IN REPUBLIC OF KOREA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Figure 37 GASTRIC ELECTRICAL STIMULATION (GES) MARKET IN REPUBLIC OF KOREA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Figure 38 REST OF ASIA INTERNAL NEUROSTIMULATION MARKET OVERVIEW, 2014 & 2019 (%)
Figure 39 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN REST OF ASIA, BY MODALITY, 2013–2019 (USD THOUSAND)
Figure 40 SPINAL CORD STIMULATION (SCS) MARKET IN REST OF ASIA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Figure 41 DEEP BRAIN STIMULATION (DBS) MARKET IN REST OF ASIA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Figure 42 SACRAL NERVE STIMULATION (SNS) MARKET IN REST OF ASIA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Figure 43 VAGUS NERVE STIMULATION (VNS) MARKET IN REST OF ASIA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Figure 44 GASTRIC ELECTRICAL STIMULATION (GES) MARKET IN REST OF ASIA, BY APPLICATION, 2013 - 2019 (USD THOUSAND)
Figure 45 INTERNAL NEUROSTIMULATION/ NEUROMODULATION MARKET: BY COMPANY
Figure 46 BOSTON SCIENTIFIC CORPORATION REVENUE MIX, 2013
Figure 47 JOHNSON & JOHNSON, INC. REVENUE MIX, 2013
Figure 48 MEDTRONIC, INC. REVENUE MIX, 2013
Figure 49 ST. JUDE MEDICAL. REVENUE MIX, 2013
